Bio-Matrix Scientific Group Inc. Chairman Sees Future of Stem Cell Therapies Focused on Stem Cell Repositories
SAN DIEGO, Sept. 30, 2010 (GLOBE NEWSWIRE) -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) Chairman & CEO David Koos commented today about the future of stem cell therapy and how advances in regenerative medicine will fuel demand for stem cell repositories.